Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Change in Receivables (2021)

Medicinova (MNOV) has disclosed Change in Receivables for 2 consecutive years, with $4.0 million as the latest value for Q1 2021.

  • Quarterly Change in Receivables changed N/A to $4.0 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was -$12.0 million through Mar 2021, changed N/A year-over-year, with the annual reading at -$6.0 million for FY2014, 200.0% down from the prior year.
  • Change in Receivables for Q1 2021 was $4.0 million at Medicinova, up from -$10.0 million in the prior quarter.
  • The five-year high for Change in Receivables was $4.0 million in Q1 2021, with the low at $4.0 million in Q1 2021.